April 26, 2017
A voluntary, nationwide, Class III recall for a single lot of penicillin V potassium tablets, USP, 500 mg (800,000 units), was announced in the latest US Food and Drug Administration (FDA) Enforcement Report.
The FDA report states that the recall was prompted after amoxicillin 500 mg was discovered in bottles of penicillin V potassium tablets, USP, 500 mg.
Citron Pharma LLC is recalling 420 bottles (with each bottle containing 1000 tablets) with the following lot number: PE5015069-A (expiration date, 11/2018).
Penicillin V potassium is an antibiotic used to treat mild to moderately severe infections due to penicillin G-sensitive microorganisms, including certain types of Streptococcal infections (without bacteremia) and Pneumococcal infections, among others.
Citron Pharma LLC voluntarily initiated the ongoing recall on February 24, 2017. The FDA gave the recall a Class III designation on April 7, 2017.
—Meredith Edwards White